Table 3 Number of components (Metabolic score) and prevalence of Metabolic Syndrome among different PPARγ and ACE genotypes in all the subjects studied and in the untreated patients group

2.6 ± 1.2

2.4 ± 1.2

0.53^a

2.7 ± 1.3

2.5 ± 1.2

2.4 ± 1.1

0.23^a

53.3

53.4

0.57^b

58.7

51.5

45.5

0.20^b

PP (143)

XA (18)

DD (55)

ID (84)

II (22)

2.01 ± 1.2

2.11 ± 1.1

0.74

2.11 ± 1.2

2.10 ± 1.2

1.55 ± 1

0.09

33.6

38.9

0.42

42.9

34.9

9.1

0.018 ^b